Pulmonx Corp Cash Flow-to-Debt Ratio
Pulmonx Corp cash flow-to-debt ratio. Pulmonx Corp (LUNG) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2026, meaning its operating cash flow of $-5.21 Million could theoretically repay 0% of its total liabilities ($75.54 Million) in one year. See LUNG financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pulmonx Corp (2013–2025)
Cash flow-to-debt ratio of Pulmonx Corp from 2013 to 2025. Historical debt coverage capacity for Pulmonx Corp across 13 annual periods. Also explore Pulmonx Corp net asset momentum to track the company's year-over-year net asset growth rate.
Pulmonx Corp Cash Flow-to-Debt Ratio by Year (2013–2025)
Pulmonx Corp cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Pulmonx Corp. For the full cash flow conversion analysis, see LUNG operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.43x | $-32.45 Million | $75.17 Million | ▼ -5.4% |
| 2024 | -0.41x | $-31.54 Million | $77.04 Million | ▲ +35.3% |
| 2023 | -0.63x | $-37.61 Million | $59.47 Million | ▲ +44.4% |
| 2022 | -1.14x | $-45.14 Million | $39.67 Million | ▼ -15.2% |
| 2021 | -0.99x | $-41.43 Million | $41.93 Million | ▼ -21.2% |
| 2020 | -0.82x | $-30.63 Million | $37.57 Million | ▼ -845.9% |
| 2019 | -0.09x | $-20.77 Million | $240.91 Million | ▲ +14.6% |
| 2018 | -0.10x | $-18.39 Million | $182.34 Million | ▲ +96.7% |
| 2017 | -3.03x | $-4.64 Million | $1.53 Million | ▼ -409.4% |
| 2016 | -0.60x | $-2.03 Million | $3.41 Million | ▲ +14.8% |
| 2015 | -0.70x | $-2.56 Million | $3.66 Million | ▲ +1.6% |
| 2014 | -0.71x | $-1.34 Million | $1.89 Million | ▼ -64.6% |
| 2013 | -0.43x | $-811.78K | $1.88 Million | — |